GlassScriptPhysician profile
Catherine A Mazzola
NPI 1295792380
$2,107.99
in general payments reported to CMS, 2019-2025
32 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $163 · 2021: $479 · 2022: $436 · 2023: $300 · 2024: $518 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918 · Education: $7.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.19 |
| Education | $7.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $766.71 | 2019-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Cusa Clarity |
| Livanova USA, INC. | $234.47 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Arkis Biosciences INC | $165.63 | 2019-2020 | |
| Neuropace, INC. | $132.38 | 2022 | |
| Ucb, INC. | $74.38 | 2023-2024 | Briviact |
| Alexion Pharmaceuticals, INC. | $50.23 | 2023-2024 | Koselugo |
| Travere Therapeutics, INC. | $46.74 | 2019-2023 | Cholbam |
| Corium, LLC | $46.71 | 2022-2024 | Azstarys |
| Neurelis, INC. | $44.73 | 2022-2023 | Valtoco |
| Depuy Synthes Sales INC. | $42.63 | 2022 | |
| Medtronic, INC. | $40.03 | 2023-2024 | Synchromedii, Strata |
| Karl Storz Endoscopy-America | $37.04 | 2023 | |
| Aquestive Therapeutics, INC. | $32.06 | 2022-2024 | |
| Piramal Critical Care | $31.30 | 2020 | |
| Bioventus LLC | $31.14 | 2022-2025 | Bonescalpel & Sonicone (O.R.) |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $29.00 | 2022-2024 | Cotempla Xr-Odt |
| Immedica Pharma US, INC. | $28.06 | 2023-2024 | |
| Medtronic USA, INC. | $24.04 | 2019 | |
| Intrabio INC | $22.58 | 2025 | Aqneursa |
| Phadia US INC. | $21.75 | 2024 | Immunocap |
| Jazz Pharmaceuticals INC. | $20.45 | 2024 | |
| Ultragenyx Pharmaceutical INC. | $20.45 | 2021 | |
| Itf Therapeutics LLC | $19.50 | 2024 | |
| Biomarin Pharmaceutical INC. | $19.41 | 2021 | |
| Mimedx Group, INC. | $19.19 | 2025 | |
| Acadia Pharmaceuticals INC | $17.36 | 2024 | Daybue |
| Azurity Pharmaceuticals, INC. | $17.21 | 2025 | Zonisade |
| Neurocrine Biosciences, INC. | $15.83 | 2025 | |
| Allergan, INC. | $15.03 | 2021 | |
| Ptc Therapeutics, INC. | $14.62 | 2022 | |
| Poriferous LLC | $13.79 | 2023 | Su-Por Surgical Implants |
| Tris Pharma INC | $13.54 | 2024 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Mazzola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.